What is the recommended antibiotic treatment for chlamydia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Antibiotic Treatment for Chlamydia

For uncomplicated genital chlamydia in non-pregnant adults, treat with either azithromycin 1 g orally as a single dose OR doxycycline 100 mg orally twice daily for 7 days—both achieve approximately 97-98% cure rates and are equally effective. 1, 2, 3

First-Line Treatment Selection

Choose azithromycin 1 g single dose when:

  • Compliance with a 7-day regimen is questionable 1, 2, 3
  • Follow-up is unpredictable or patient has erratic health-care-seeking behavior 4, 1, 3
  • Directly observed therapy is needed (particularly in adolescents and young adults) 1, 3
  • Single-dose convenience outweighs cost considerations 4, 1

Choose doxycycline 100 mg twice daily for 7 days when:

  • Cost is a primary concern, as doxycycline is significantly less expensive 2, 3
  • Patient can reliably complete a 7-day course 3
  • Extensive clinical experience is preferred 2

Alternative Regimens (Only When First-Line Options Cannot Be Used)

The following alternatives have lower efficacy or tolerability: 1, 3

  • Levofloxacin 500 mg orally once daily for 7 days 1, 3
  • Ofloxacin 300 mg orally twice daily for 7 days 4, 1, 3
  • Erythromycin base 500 mg orally four times daily for 7 days 4, 1, 3
  • Erythromycin ethylsuccinate 800 mg orally four times daily for 7 days 4, 1, 3

Critical caveat: Erythromycin causes frequent gastrointestinal side effects that lead to poor compliance, making it less desirable than first-line options. 2, 3

Treatment During Pregnancy

Azithromycin 1 g orally as a single dose is the preferred treatment during pregnancy. 1, 3

Alternative options for pregnant women:

  • Amoxicillin 500 mg orally three times daily for 7 days 1, 2, 3
  • Erythromycin base 500 mg orally four times daily for 7 days 1, 3

Absolute contraindications in pregnancy: Doxycycline, ofloxacin, and levofloxacin are contraindicated due to potential fetal harm. 1, 3

Mandatory follow-up: Pregnant women must undergo test-of-cure 3-4 weeks after treatment completion due to potential maternal and neonatal complications. 1, 3

Pediatric Dosing

For children ≥8 years weighing >45 kg: 1, 3

  • Azithromycin 1 g orally as a single dose, OR
  • Doxycycline 100 mg orally twice daily for 7 days

For children <45 kg: 1, 3

  • Erythromycin base or ethylsuccinate 50 mg/kg/day orally divided into four doses daily for 14 days

For infants with chlamydial pneumonia (ages 1-3 months): 1

  • Erythromycin base or ethylsuccinate 50 mg/kg/day orally divided into four doses daily for 14 days
  • Treatment effectiveness is approximately 80%, and a second course may be needed 1

Critical Implementation Steps to Maximize Cure Rates

Medication dispensing: 1, 3

  • Dispense medications on-site when possible
  • Directly observe the first dose to maximize compliance

Sexual abstinence requirements: 1, 3

  • Patients must abstain from all sexual intercourse for 7 days after initiating treatment
  • Continue abstinence until all sex partners have completed treatment

Partner management (essential to prevent reinfection): 1, 3

  • All sex partners from the preceding 60 days must be evaluated, tested, and empirically treated
  • Failing to treat sex partners leads to reinfection in up to 20% of cases 1

Follow-Up and Retesting Strategy

Test-of-cure is NOT recommended for non-pregnant patients treated with azithromycin or doxycycline because treatment failure rates are extremely low (0-3% in males, 0-8% in females). 1, 3

Test-of-cure IS indicated when: 1, 3

  • Therapeutic compliance is questionable
  • Symptoms persist after treatment
  • Reinfection is suspected
  • Testing before 3 weeks post-treatment is unreliable due to false-positive results from dead organisms 1

Reinfection screening (distinct from test-of-cure): 1, 3

  • All women with chlamydia should be retested approximately 3 months after treatment, regardless of whether partners were reportedly treated
  • Reinfection rates can reach 39% in some adolescent populations 3
  • Repeat infections carry elevated risk for pelvic inflammatory disease and complications compared to initial infection 1

Special Considerations

Coinfection with gonorrhea: 1

  • Coinfection with gonorrhea is common among chlamydia patients
  • If gonorrhea is confirmed, always treat chlamydia concurrently due to high coinfection rates

Rectal chlamydia in men who have sex with men: 5

  • Recent high-quality evidence shows doxycycline 100 mg twice daily for 7 days is superior to azithromycin 1 g single dose for asymptomatic rectal chlamydia (96.9% vs 76.4% cure rate, P<0.001)
  • For rectal chlamydia, strongly prefer doxycycline over azithromycin

Common pitfall to avoid: Do not wait for test results if compliance with return visit is uncertain in high-prevalence populations—treat presumptively. 1

References

Guideline

Chlamydia Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Chlamydia Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Chlamydia Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.